To the full analysis
Solvay stock: growth
SOLB.BRSolvay reported $5.26B in revenue for fiscal 2025, down 7.5% on the prior year, down 13.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−3.5%
per year from 2006 to 2025, per share −4.4%
Earnings (Annual rate)
−16%
per year from 2006 to 2025, per share −16.5%
Free cash flow (Annual rate)
−1.7%
per year from 2006 to 2025, per share −2.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −13.3% | −8.1% | −3.5% |
| Revenue per share | −13.6% | −10.1% | −4.4% |
| Earnings | no data | −22.9% | −16.0% |
| Earnings per share | no data | −24.5% | −16.5% |
| Free cash flow | −10.6% | 1.4% | −1.7% |
| Free cash flow per share | −10.8% | −0.8% | −2.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $10.42B | $905.32M | $617.21M |
| 2007 | $10.61B | $917.51M | $464.29M |
| 2008 | $10.52B | $497.54M | $587.29M |
| 2009 | $9.4B | $612.78M | $806.7M |
| 2010 | $7.88B | $2.02B | $366.78M |
| 2011 | $8.99B | $329.11M | $212.76M |
| 2012 | $14.22B | $647.13M | $744.64M |
| 2013 | $11.49B | $299.19M | $518.59M |
| 2014 | $11.78B | $88.65M | $702.54M |
| 2015 | $12.24B | $449.89M | $388.94M |
| 2016 | $12.64B | $688.13M | $894.24M |
| 2017 | $12.07B | $1.18B | $866.53M |
| 2018 | $12.52B | $950.75M | $982.88M |
| 2019 | $12.44B | −$87.54M | $1.06B |
| 2020 | $10.76B | −$1.21B | $783.43M |
| 2021 | $12.67B | $1.05B | $956.29M |
| 2022 | $17.81B | $2.11B | $1.22B |
| 2023 | $6.68B | $2.32B | $938.56M |
| 2024 | $5.68B | $247.11M | $365.67M |
| 2025 | $5.26B | $33.24M | $447.67M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 14 Aug 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.